title: GM1 improves neurofascin155 association with lipid rafts and prevents rat brain myelin injury after hypoxia-ischemia.
abstract: White matter injury characterized by damage to myelin is an important process in hypoxic-ischemic brain damage (HIBD). Because the oligodendrocyte-specific isoform of neurofascin, neurofascin 155 (NF155), and its association with lipid rafts are essential for the establishment and stabilization of the paranodal junction, which is required for tight interaction between myelin and axons, we analyzed the effect of monosialotetrahexosyl ganglioside (GM1) on NF155 expression and its association with lipid rafts after HIBD in Sprague-Dawley rats, weighing 12-15 g, on day 7 post-partum (P7; N = 20 per group). HIBD was induced on P7 and the rats were divided into two groups: one group received an intraperitoneal injection of 50 mg/kg GM1 three times and the other group an injection of saline. There was also a group of 20 sham-operated rats. After sacrifice, the brains of the rats were removed on P30 and studied by immunochemistry, SDS-PAGE, Western blot analysis, and electron microscopy. Staining showed that the saline group had definite rarefaction and fragmentation of brain myelin sheaths, whereas the GM1 group had no obvious structural changes. The GM1 group had 1.9-2.9-fold more GM1 in lipid rafts than the saline group (fraction 3-6; all P < 0.05) and 0.5-2.4-fold higher expression of NF155 in lipid rafts (fraction 3-5; all P < 0.05). Injection of GM1 increased the content of GM1 in lipid rafts as well as NF155 expression and its lipid raft association in HIBD rat brains. GM1 may repair the structure of lipid rafts, promote the association of NF155 (or other important proteins) with lipid rafts, stabilize the structure of paranodes, and eventually prevent myelin sheath damage, suggesting a novel mechanism for its neuroprotective properties.
authors.affiliation: Department of Neurosurgery, Third Military Medical University, 183 Xinqiao Main Street, Chongqing, China.
authors.forename: Y P
authors.initials: YP
authors.lastname: Zhang
authors.forename: Q L
authors.initials: QL
authors.lastname: Huang
authors.forename: C M
authors.initials: CM
authors.lastname: Zhao
authors.forename: J L
authors.initials: JL
authors.lastname: Tang
authors.forename: Y L
authors.initials: YL
authors.lastname: Wang
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D015153:Blotting, Western; D001921:Brain / Q000648:ultrastructure; D015815:Cell Adhesion Molecules / Q000378:metabolism*; D005260:Female; D005677:G(M1) Ganglioside / Q000378:metabolism* / Q000494:pharmacology*; D020925:Hypoxia-Ischemia, Brain / Q000378:metabolism* / Q000473:pathology; D007274:Injections, Intraperitoneal; D008297:Male; D008563:Membrane Lipids / Q000378:metabolism*; D008854:Microscopy, Electron; D009186:Myelin Sheath / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D009414:Nerve Growth Factors / Q000378:metabolism*; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D015815:Cell Adhesion Molecules; D008563:Membrane Lipids; C054305:NFASC protein, human; D009414:Nerve Growth Factors; D005677:G(M1) Ganglioside